Contract development and manufacturing organization (CDMO), Sterling Pharma Solutions, has signed a deal with clinical stage pharmaceutical company, Moleculin Biotech, to support the development of WP1122, a potential COVID-19 treatment.
According to a July 27, 2020 press release, Moleculi
